TY - JOUR
KW - Humans
KW - Aged
KW - *COVID-19 Vaccines
KW - Retrospective Studies
KW - State Medicine
KW - *COVID-19/diagnosis/epidemiology
KW - England/epidemiology
KW - Covid-19
KW - epidemiology
KW - Primary health care
AU - K. Andersen
AU - L. McGrath
AU - M. Reimbaeva
AU - D. Mendes
AU - J. Nguyen
AU - K. Rai
AU - T. Tritton
AU - C. Tsang
AU - D. Malhotra
AU - J. Yang
AD - Pfizer Inc, New York, New York, USA kathleen.andersen@pfizer.com.
Pfizer Inc, New York, New York, USA.
Pfizer Ltd, Tadworth, UK.
Adelphi Real World, Bollington, UK.
Institute for Social and Economic Research and Policy, Columbia University, New York, New York, USA.
AN - 38216179
BT - BMJ Open
C2 - PMC10806788
DO - 10.1136/bmjopen-2023-073866
DP - NLM
ET - 2024/01/13
LA - eng
M1 - 1
N1 - 2044-6055
Andersen, Kathleen M
Orcid: 0000-0003-2670-800x
McGrath, Leah J
Reimbaeva, Maya
Mendes, Diana
Nguyen, Jennifer L
Rai, Kiran K
Tritton, Theo
Tsang, Carmen
Malhotra, Deepa
Yang, Jingyan
Journal Article
Research Support, Non-U.S. Gov't
England
BMJ Open. 2024 Jan 11;14(1):e073866. doi: 10.1136/bmjopen-2023-073866.
PY - 2024
SN - 2044-6055
EP - e073866
T2 - BMJ Open
TI - Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description
VL - 14
ER -